Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY: A NEW POSSIBILITY FOR COVID- 19 TREATMENT

Detalles Bibliográficos
Autores principales: Kim, N., Lee, J., Oh, E., Jekarl, D., Lee, D., Im, K., Cho, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2022
Materias:
POSTER ABSTRACTS: Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035761/
http://dx.doi.org/10.1016/S1465-3249(22)00303-6
_version_ 1784693368800935936
author Kim, N.
Lee, J.
Oh, E.
Jekarl, D.
Lee, D.
Im, K.
Cho, S.
author_facet Kim, N.
Lee, J.
Oh, E.
Jekarl, D.
Lee, D.
Im, K.
Cho, S.
author_sort Kim, N.
collection PubMed
description
format Online
Article
Text
id pubmed-9035761
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society for Cell & Gene Therapy. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-90357612022-04-25 Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY: A NEW POSSIBILITY FOR COVID- 19 TREATMENT Kim, N. Lee, J. Oh, E. Jekarl, D. Lee, D. Im, K. Cho, S. Cytotherapy POSTER ABSTRACTS: Immunotherapy International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2022-05 2022-04-25 /pmc/articles/PMC9035761/ http://dx.doi.org/10.1016/S1465-3249(22)00303-6 Text en Copyright © 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle POSTER ABSTRACTS: Immunotherapy
Kim, N.
Lee, J.
Oh, E.
Jekarl, D.
Lee, D.
Im, K.
Cho, S.
Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY: A NEW POSSIBILITY FOR COVID- 19 TREATMENT
title Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY: A NEW POSSIBILITY FOR COVID- 19 TREATMENT
title_full Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY: A NEW POSSIBILITY FOR COVID- 19 TREATMENT
title_fullStr Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY: A NEW POSSIBILITY FOR COVID- 19 TREATMENT
title_full_unstemmed Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY: A NEW POSSIBILITY FOR COVID- 19 TREATMENT
title_short Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY: A NEW POSSIBILITY FOR COVID- 19 TREATMENT
title_sort immunotherapy: off-the-shelf partial hla matching sars-cov-2 antigen specific t cell therapy: a new possibility for covid- 19 treatment
topic POSTER ABSTRACTS: Immunotherapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035761/
http://dx.doi.org/10.1016/S1465-3249(22)00303-6
work_keys_str_mv AT kimn immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyanewpossibilityforcovid19treatment
AT leej immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyanewpossibilityforcovid19treatment
AT ohe immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyanewpossibilityforcovid19treatment
AT jekarld immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyanewpossibilityforcovid19treatment
AT leed immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyanewpossibilityforcovid19treatment
AT imk immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyanewpossibilityforcovid19treatment
AT chos immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyanewpossibilityforcovid19treatment

Ejemplares similares